Agoracom: Small Cap Investment - Pluristem Life Systems, Inc. - Re: Pluristem Completes Enrollment for Phase I/II Muscle Injury Trial

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Back To Forum List View

Pluristem Completes Enrollment for Phase I/II Muscle Injury Trial

emma

Jul 11, 2013 09:00AM

bankerson

Rank: Treasurer [?]

Points: 22820 [?]

Votes: 138 Score: 2.9 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Pluristem Completes Enrollment for Phase I/II Muscle Injury Trial

in response to

Pluristem Completes Enrollment for Phase I/II Muscle Injury Trial

emma

posted on Jul 11, 2013 10:43AM

Thanks emma!.... just heard of another person who needs this technology... hope it happens soon.

Reply New Message

Back To Forum List View

Please to post a reply